Segment Information (Tables)

3 Months Ended

Dec. 31, 2012

Six Months Ended December 31, 2012 and 2011:

	Human Health		Pharmaceutical Ingredients		Performance Chemicals		Unallocated Corporate			Consolidated Totals
2012
Net sales	$	56,260	$	80,393	$	89,051	$	-		$	225,704
Gross profit		17,010		12,047		13,156		-			42,213
Income (loss) before income taxes		7,371		3,638		5,381		(1,670	)		14,720

2011
Net sales	$	50,061	$	80,957	$	81,006	$	-		$	212,024
Gross profit		15,062		12,469		11,632		-			39,163
Income (loss) before income taxes		6,846		3,949		4,091		(2,983	)		11,903

Three Months Ended December 31, 2012 and 2011:

	Human Health		Pharmaceutical Ingredients		Performance Chemicals		Unallocated Corporate			Consolidated Totals
2012
Net sales	$	29,851	$	39,785	$	44,320	$	-		$	113,956
Gross profit		8,907		5,471		6,330		-			20,708
Income (loss) before income taxes		4,252		1,085		2,296		(535	)		7,098

2011
Net sales	$	27,308	$	38,648	$	44,751	$	-		$	110,707
Gross profit		8,471		5,697		6,476		-			20,644
Income (loss) before income taxes		4,295		1,069		2,501		(701	)		7,164

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details